Navigation Links
RoosterBio Launches a Closed System Extracellular Vesicle Collection Medium Enabling Scalable and Standardized cGMP Manufacturing
Date:5/15/2020

RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC bioprocess systems, today announced the launch of its product RoosterCollect™-EV-CC to enable streamlined and multi-format collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with hMSC-EV product developers in mind. Product developers can now use RoosterBio’s CliniControl™ standardized, scalable and highly productive bioprocess media with high quality cellular starting materials to reduce costs and process times – completing a system for EV production that can readily be implemented in late stage product development and cGMP manufacturing.

In March 2019, RoosterBio brought RoosterCollect™-EV and EV Boost™, “development grade” versions of the product system, successfully to market while outpacing expected sales forecasts. Founder and Chief Product Officer Jon A. Rowley, PhD said, “We launched RoosterCollect™-EV-CC in response to strong market demand for a complete hMSC-EV system. This solution solves the need of the regenerative medicine product developer who requires significant hMSC-derived EV volumes generated from cGMP systems designed with quality, efficiency and scalability in mind.”

Today, a wide range of companies are currently developing EV/exosome-based therapeutic products across diverse applications in the regenerative medicine industry. The EV market is rapidly growing with at least 13,074 scientific articles published, according to PubMed.gov and over 140 clinical trials underway, according to Clinicaltrials.gov. hMSCs are reportedly prolific producers of EVs, and are hypothesized to have mechanism of action attributable to EV secretion into the extracellular space. EVs are also being considered as targetable candidate delivery systems for macromolecules like siRNA or miRNA.

RoosterBio’s proprietary, clinically relevant product portfolio manufactured by GenCure was introduced in 2017 under the CliniControl™ brand name. CliniControl™ products radically simplify multiple steps in therapeutic development, allowing product developers to prospectively truncate years of time and millions of dollars from their development timelines.

Rowley added, “This product is a key addition to our cGMP solutions. We’ve proven that our CliniControl™ products are part of the industrialized supply chain of regenerative medicine. We continue to drive unparalleled efficiencies and economies of scale in clinical and commercial hMSC-based product manufacturing.”

About RoosterBio, Inc.
RoosterBio, Inc. is a privately held cell manufacturing platform technology company focused on accelerating the development of a sustainable Regenerative Medicine industry, one customer at a time. RoosterBio's products are high-volume, cost-effective, and well-characterized adult human mesenchymal stem/stromal cells (hMSCs) paired with highly engineered media systems. RoosterBio has simplified and standardized how living cells are purchased, expanded, and used in development, leading to marked time and cost savings for customers. RoosterBio's innovative products and collaborative relationships are ushering in a new era of productivity and standardization into the field. Visit http://www.roosterbio.com.

Read the full story at https://www.prweb.com/releases/roosterbio_launches_a_closed_system_extracellular_vesicle_collection_medium_enabling_scalable_and_standardized_cgmp_manufacturing/prweb17120166.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology technology :

1. Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology
2. RoosterBio Inc. Launches Industry’s First Ready-to-Print Stem Cell Product
3. Designed by RoosterBio Inc.: New Xeno-free Cell Culture Media Product Developed to Accelerate Manufacturing and Commercialization of Adult Stem Cell Products
4. Engineered by RoosterBio Inc.: Universal Bioprocess Bags to Streamline Closed System Stem Cell Production
5. RoosterBio Inc. Unites with Manufacturing Innovation Institutes, Joining Manufacturing USA Network
6. RoosterBio Launches a Xeno-Free Bioreactor Feed to Streamline Cell Expansion & Efficiently Reach Billions of hMSCs
7. Margot Connor, CEO, RoosterBio Inc., Frederick Innovative Technology Center, Inc expected graduate earns “Top 10” Technology Industry Award
8. RoosterBio Launches New cGMP Stem Cell Product Portfolio, Maintaining Unwavering Commitment to Driving the Explosive Regenerative Medicine Industry
9. RoosterBio and GenCure Sign Multiple Agreements to Advance Regenerative Medicine Startups
10. RoosterBio Partners with Senti Biosciences to Rapidly Translate Gene Circuit Cell Therapy into the Clinic
11. Darrow Wealth Management Launches New Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2020)... ... , ... Brilliant , the leading smart home control and lighting company, ... a new integration to bring more convenience, simplicity, and security to the smart home ... can now be controlled from Brilliant’s in-wall touchscreen control panels and mobile app. ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... cell banks and hMSC bioprocess systems, today announced the launch of its ... extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with hMSC-EV product ...
(Date:5/14/2020)... ... May 12, 2020 , ... NanoString Technologies ... together thousands of industry leaders, clinicians, research scientists, medical professionals and academics from ... June, MD, Director of the Center for Cellular Immunotherapies at the Perelman School ...
(Date:5/5/2020)... , ... May 05, 2020 , ... ProductLife Group ... high-profile CEO. Xavier Duburcq joins the group after 13 years at Altran, where he ... Holding a PhD in Immunology and being a Pharmacist, Xavier was involved in his ...
Breaking Biology Technology:
(Date:5/28/2020)... , ... May 27, 2020 , ... ... Workforce Advisor™ , a solution that uniquely combines lab testing insights and ... employers systematically support the ongoing health and safety of employees returning to the ...
(Date:5/21/2020)... ... May 21, 2020 , ... ... technology-based services specializing in background and medical screening, announces the launch of ... and keeping their workforce safe. The new service is provided by ClearStar’s ...
(Date:5/15/2020)... ... 15, 2020 , ... The National Institutes of Health (NIH) has selected McBee ... Maryland and Tysons Corner, Virginia, to provide patent legal services under two separate ten ... field of chemistry. The firm is one of nine firms in the nation awarded ...
Breaking Biology News(10 mins):